Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ASN-008 by Libertas Bio for Pruritus: Likelihood of Approval
ASN-008 is under clinical development by Libertas Bio and currently in Phase II for Pruritus. According to GlobalData, Phase II...
Data Insights
ASN-008 by Libertas Bio for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
ASN-008 is under clinical development by Libertas Bio and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...